We aimed to provide recommendations on the infusion duration of anthracycline chemotherapy agents in children with cancer” Loeffen et al (2017).
Abstract:
We aimed to provide recommendations on the infusion duration of anthracycline chemotherapy agents in children with cancer. This study also serves as a practice example of the essential steps that need to be taken when using a previously published systematic review to develop a high-quality clinical practice guideline. Although evidence was scarce and included adult studies, the panel was able (using the Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework) to recommend in favor of an anthracycline infusion duration of at least 1 hr (strong recommendation, very low to moderate quality of evidence). Recommending a precise optimal prolonged infusion duration was currently not possible.
[ctt link=”hmT8M” template=”1″]ReTweet if useful… What is the duration of anthracycline infusion in children with cancer? https://ctt.ec/hmT8M+ @ivteam #ivteam[/ctt]
Reference:
Loeffen, E.A.H., van Dalen, E.C., Mulder, R.L., van de Wetering, M.D., Kremer, L.C.M. and Tissing, W.J.E. (2017) The duration of anthracycline infusion should be at least one hour in children with cancer: A clinical practice guideline. Pediatric Blood & Cancer. October 27th. [epub ahead of print].
DOI: 10.1002/pbc.26867
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]